These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33921709)

  • 1. MET Exon 14 Skipping: A Case Study for the Detection of Genetic Variants in Cancer Driver Genes by Deep Learning.
    Nosi V; Luca A; Milan M; Arigoni M; Benvenuti S; Cacchiarelli D; Cesana M; Riccardo S; Di Filippo L; Cordero F; Beccuti M; Comoglio PM; Calogero RA
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA-Based versus RNA-Based Detection of MET Exon 14 Skipping Events in Lung Cancer.
    Davies KD; Lomboy A; Lawrence CA; Yourshaw M; Bocsi GT; Camidge DR; Aisner DL
    J Thorac Oncol; 2019 Apr; 14(4):737-741. PubMed ID: 30639620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MET Exon 14 Skipping in Non-Small Cell Lung Cancer.
    Heist RS; Shim HS; Gingipally S; Mino-Kenudson M; Le L; Gainor JF; Zheng Z; Aryee M; Xia J; Jia P; Jin H; Zhao Z; Pao W; Engelman JA; Iafrate AJ
    Oncologist; 2016 Apr; 21(4):481-6. PubMed ID: 27022036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [MET Exon 14 Skipping Mutations in Non-small Cell Lung Cancer].
    Yin L; Lu Y
    Zhongguo Fei Ai Za Zhi; 2018 Jul; 21(7):553-559. PubMed ID: 30037377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired Resistance to Crizotinib in NSCLC with MET Exon 14 Skipping.
    Heist RS; Sequist LV; Borger D; Gainor JF; Arellano RS; Le LP; Dias-Santagata D; Clark JW; Engelman JA; Shaw AT; Iafrate AJ
    J Thorac Oncol; 2016 Aug; 11(8):1242-1245. PubMed ID: 27343442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Novel MET Exon 14 Skipping Variants in Non-Small Cell Lung Cancer Patients: A Prototype Workflow Involving in Silico Prediction and RT-PCR.
    Das R; Jakubowski MA; Spildener J; Cheng YW
    Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ExonSkipDB: functional annotation of exon skipping event in human.
    Kim P; Yang M; Yiya K; Zhao W; Zhou X
    Nucleic Acids Res; 2020 Jan; 48(D1):D896-D907. PubMed ID: 31642488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capmatinib for patients with non-small cell lung cancer with MET exon 14 skipping mutations: A review of preclinical and clinical studies.
    Wu YL; Smit EF; Bauer TM
    Cancer Treat Rev; 2021 Apr; 95():102173. PubMed ID: 33740553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations.
    Schrock AB; Frampton GM; Suh J; Chalmers ZR; Rosenzweig M; Erlich RL; Halmos B; Goldman J; Forde P; Leuenberger K; Peled N; Kalemkerian GP; Ross JS; Stephens PJ; Miller VA; Ali SM; Ou SH
    J Thorac Oncol; 2016 Sep; 11(9):1493-502. PubMed ID: 27343443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and Clinical Outcomes of Non-small Cell Lung Cancer Patients in Korea With
    Hur JY; Ku BM; Shim JH; Jung HA; Sun JM; Lee SH; Ahn JS; Park K; Ahn MJ
    In Vivo; 2020; 34(3):1399-1406. PubMed ID: 32354937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of Preexisting MET Y1230C Mutation as a Resistance Mechanism to Crizotinib in NSCLC with MET Exon 14 Skipping.
    Ou SI; Young L; Schrock AB; Johnson A; Klempner SJ; Zhu VW; Miller VA; Ali SM
    J Thorac Oncol; 2017 Jan; 12(1):137-140. PubMed ID: 27666659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of exon-skipping events on chromosome 22 to protein coding diversity.
    Hide WA; Babenko VN; van Heusden PA; Seoighe C; Kelso JF
    Genome Res; 2001 Nov; 11(11):1848-53. PubMed ID: 11691849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of MET Exon 14 Skipping Alterations in Lung Cancer Clinical Samples Using a PCR-Based Approach.
    Sui JSY; Finn SP; Gray SG
    Methods Mol Biol; 2021; 2279():145-155. PubMed ID: 33683691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly accurate DNA-based detection and treatment results of MET exon 14 skipping mutations in lung cancer.
    Pruis MA; Geurts-Giele WRR; von der TJH; Meijssen IC; Dinjens WNM; Aerts JGJV; Dingemans AMC; Lolkema MP; Paats MS; Dubbink HJ
    Lung Cancer; 2020 Feb; 140():46-54. PubMed ID: 31862577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intron-exon structure of the MET gene and cloning of an alternatively-spliced Met isoform reveals frequent exon-skipping of a single large internal exon.
    Lin JC; Naujokas M; Zhu H; Nolet S; Park M
    Oncogene; 1998 Feb; 16(7):833-42. PubMed ID: 9484774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MET exon 14 mutations as targets in routine molecular analysis of primary sarcomatoid carcinoma of the lung.
    Saffroy R; Fallet V; Girard N; Mazieres J; Sibilot DM; Lantuejoul S; Rouquette I; Thivolet-Bejui F; Vieira T; Antoine M; Cadranel J; Lemoine A; Wislez M
    Oncotarget; 2017 Jun; 8(26):42428-42437. PubMed ID: 28418914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid Disease Progression in a Patient with Advanced NSCLC Harboring a Germline
    Jiao Y; Fang C; Yang Y; Shao L; Huang Y; Sun Q; Dong Y
    Onco Targets Ther; 2021; 14():2417-2421. PubMed ID: 33854337
    [No Abstract]   [Full Text] [Related]  

  • 18. Next-Generation Sequencing of Pulmonary Sarcomatoid Carcinoma Reveals High Frequency of Actionable MET Gene Mutations.
    Liu X; Jia Y; Stoopler MB; Shen Y; Cheng H; Chen J; Mansukhani M; Koul S; Halmos B; Borczuk AC
    J Clin Oncol; 2016 Mar; 34(8):794-802. PubMed ID: 26215952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracranial Activity of Cabozantinib in MET Exon 14-Positive NSCLC with Brain Metastases.
    Klempner SJ; Borghei A; Hakimian B; Ali SM; Ou SI
    J Thorac Oncol; 2017 Jan; 12(1):152-156. PubMed ID: 27693535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case report: HER2 amplification as a resistance mechanism to crizotinib in NSCLC with MET exon 14 skipping.
    Ding G; Wang J; Ding P; Wen Y; Yang L
    Cancer Biol Ther; 2019; 20(6):837-842. PubMed ID: 30744539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.